Wednesday, July 9, 2025
  • Login
CEO North America
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
No Result
View All Result
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
No Result
View All Result
CEO North America
No Result
View All Result

CEO North America > News > CVS, Walmart and Walgreens Agree to Pay $13.8 Billion for Opioid Claims

CVS, Walmart and Walgreens Agree to Pay $13.8 Billion for Opioid Claims

in News
CVS, Walmart and Walgreens Agree to Pay $13.8 Billion for Opioid Claims
Share on LinkedinShare on WhatsApp

CVS Health, Walgreens Boots Alliance and Walmart have agreed to pay about $13.8 billion to resolve thousands of lawsuits accusing the pharmacy chains of mishandling opioid painkillers.

In a filing with the Securities and Exchange Commission Walgreens disclosed that it had agreed to pay about $5.7 billion over 15 years. CVS said Wednesday it had agreed to pay about $5 billion over 10 year and Walmart has agreed to pay $3.1 billion, according to two people familiar with the matter.

Neither company admitted wrongdoing.

CVS, Walgreens and Walmart are the three largest retail pharmacies in the country by market share.

“We are pleased to resolve these longstanding claims and putting them behind us is in the best interest of all parties, as well as our customers, colleagues and shareholders,” CVS’s general counsel, Thomas Moriarty, said in a statement. The company did not admit wrongdoing.

Walgreens said in its SEC filing that it “continues to believe it has strong legal defenses” and will defend itself against any future lawsuits not covered by the settlement.

In more than 3,300 lawsuits, beginning in 2017, state and local governments accused drugmakers of downplaying the risks of their opioid pain medicines. Pharmacies were accused of ignoring red flags that prescriptions were being diverted into illegal trafficking.

Overdoses involving opioids, including prescription pills and heroin, surged further during the Covid pandemic, increasing 38% in 2020 over the previous year and another 15% in 2021, according to the Centers for Disease Control and Prevention.

Tags: CVS HealthopioidsWalgreensWalmart

Related Posts

MaintainX raises $150M, company value jumps to $2.5 billion
News

MaintainX raises $150M, company value jumps to $2.5 billion

Merck buys Verona in $10 billion deal
News

Merck buys Verona in $10 billion deal

Trump’s Truth Social App Launched This Weekend
News

Trump’s trade deadline arrives without momentum

Porsche reports 10% sales growth in North America 
News

Porsche reports 10% sales growth in North America 

The Hershey Company appoints Kirk Tanner as President and CEO
News

The Hershey Company appoints Kirk Tanner as President and CEO

Tariff deadline looms as Trump bumps tariffs up to 40%
News

Tariff deadline looms as Trump bumps tariffs up to 40%

Norges Investment Bank CEO warns of rising U.S. debt
News

Norges Investment Bank CEO warns of rising U.S. debt

Tesla shares drop as Musk announces political party
News

Tesla shares drop as Musk announces political party

New 10% tariff for nations supporting ‘anti-American’ BRICS policies
News

New 10% tariff for nations supporting ‘anti-American’ BRICS policies

Paramount CEO explains why company paid Trump millions in 60 Minutes settlement
News

Paramount CEO explains why company paid Trump millions in 60 Minutes settlement

No Result
View All Result

Recent Posts

  • Stuck in the Cross-Hairs of a Tarrif War and the AI Revolution – CEO North America Magazine Analyses Tim Cook’s Apple Strategy
  • A Comprehensive Look at Executive Incentive Plan Design
  • MaintainX raises $150M, company value jumps to $2.5 billion
  • Merck buys Verona in $10 billion deal
  • Microsoft, OpenAI and Anthropic are investing millions to train teachers how to use AI

Archives

Categories

  • Art & Culture
  • Business
  • CEO Interviews
  • CEO Life
  • Editor´s Choice
  • Entrepreneur
  • Environment
  • Food
  • Health
  • Highlights
  • Industry
  • Innovation
  • Issues
  • Management & Leadership
  • News
  • Opinion
  • PrimeZone
  • Printed Version
  • Technology
  • Travel
  • Uncategorized

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

  • CONTACT
  • GENERAL ENQUIRIES
  • ADVERTISING
  • MEDIA KIT
  • DIRECTORY
  • TERMS AND CONDITIONS

Advertising –
advertising@ceo-na.com

110 Wall St.,
3rd Floor
New York, NY.
10005
USA
+1 212 432 5800

Avenida Chapultepec 480,
Floor 11
Mexico City
06700
MEXICO

  • News
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life

  • CONTACT
  • GENERAL ENQUIRIES
  • ADVERTISING
  • MEDIA KIT
  • DIRECTORY
  • TERMS AND CONDITIONS

Advertising –
advertising@ceo-na.com

110 Wall St.,
3rd Floor
New York, NY.
10005
USA
+1 212 432 5800

Avenida Chapultepec 480,
Floor 11
Mexico City
06700
MEXICO

CEO North America © 2024 - Sitemap

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel

© 2025 JNews - Premium WordPress news & magazine theme by Jegtheme.